Literature DB >> 2831271

Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line.

B G Weinshenker1, S Wilton, G P Rice.   

Abstract

The susceptibility of four different human cell lines (HUT 102, THP-1, MOLT-4, and HL-60) to infection by human CMV (HCMV) was studied. Only HUT 102 was susceptible and only immediate-early gene products were produced. However, THP-1, a monocytic cell line, could be infected by HCMV with a full cycle of replication after treatment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA), which produced differentiation of the cell line into cells with characteristics of mature macrophages. Late (structural) Ag were demonstrated, as were infectious virions as detected by electron microscopy and infectious center assay. HL-60, a promyelocytic cell line, was not susceptible to HCMV infection after treatment with TPA despite differentiation into adherent cells with properties of macrophages, suggesting that cellular lineage was important. Treatment with TPA after infection resulted in a greatly reduced frequency of infected cells, suggesting that pretreatment was essential. Furthermore, continued presence of TPA was unnecessary after differentiation was induced. This study establishes the precedent of productive HCMV infection in human monocytic cells. The potential mechanism and relevance of enhanced replication induced by TPA are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.

Authors:  Sean M Gregory; Ling Wang; John A West; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Authors:  Ryan T Saffert; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.

Authors:  C Meyers; T J Mayer; M A Ozbun
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells.

Authors:  N Kienzle; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.

Authors:  Y F Zhou; E Guetta; Z X Yu; T Finkel; S E Epstein
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Repression by a differentiation-specific factor of the human cytomegalovirus enhancer.

Authors:  T H Huang; T Oka; T Asai; T Okada; B W Merrills; P N Gertson; R H Whitson; K Itakura
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

7.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1.

Authors:  Kong-Nan Zhao; Ian H Frazer
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.

Authors:  N Y Harel; J C Alwine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40tax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements.

Authors:  H Moch; D Lang; T Stamminger
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.